Oscar Health, Inc.
OSCR · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,230,788 | $2,028,148 | $522,688 | $1,404,891 |
| - Cash | $1,527,186 | $1,870,315 | $1,558,595 | $1,103,995 |
| + Debt | $299,555 | $298,777 | $297,999 | $0 |
| Enterprise Value | $2,003,157 | $456,610 | -$737,908 | $300,896 |
| Revenue | $9,177,941 | $5,862,869 | $4,125,584 | $1,920,961 |
| % Growth | 56.5% | 42.1% | 114.8% | – |
| Gross Profit | $9,177,941 | $5,862,869 | $4,125,584 | $1,920,961 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | $89,305 | -$212,003 | -$572,169 | -$551,255 |
| % Margin | 1% | -3.6% | -13.9% | -28.7% |
| Net Income | $25,432 | -$270,728 | -$606,275 | -$572,606 |
| % Margin | 0.3% | -4.6% | -14.7% | -29.8% |
| EPS Diluted | 0.096 | -1.22 | -2.87 | -3.19 |
| % Growth | 107.8% | 57.5% | 10% | – |
| Operating Cash Flow | $978,193 | -$272,159 | $380,349 | -$181,745 |
| Capital Expenditures | -$27,897 | -$25,577 | -$29,012 | -$25,885 |
| Free Cash Flow | $950,296 | -$297,736 | $351,337 | -$207,630 |